Custom Search Insider Trading Activity Insider Trading Activity
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
Custom Search Insider Trading Activity
Updated Aug 13, 2024
Ticker
|
Company Name
|
Qty.
|
Price
|
Size ($)
|
Filing Date
|
Type
|
Δ Own
|
Own
|
Insider Names
|
Title
|
Trade Dates
|
Is Scheduled
| |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Meiragtx Holdings Plc
|
0
|
—
|
—
|
—
|
0
| ||||||||
Translate Bio, Inc.
| 71.98M |
$38.00 | $2,735,376,686.00 | +1,953.72% | 75.67M |
Sep 14
| |||||||
Translate Bio, Inc.
|
0
|
—
|
—
|
—
|
0
| ||||||||
Icosavax, Inc.
| 3.16M |
$15.00 | $1,000,005.00 |
∞
| 3.16M |
Aug 2
| |||||||
Icosavax, Inc.
|
0
|
—
|
—
|
—
|
0
| ||||||||
Inozyme Pharma, Inc.
| 520.13K |
$16.00 | $1,300,000.00 |
∞
| 520.13K |
Jul 28
| |||||||
Inozyme Pharma, Inc.
|
0
|
—
|
—
|
—
|
0
| ||||||||
Regeneron Pharmaceuticals, Inc.
| -120.23K |
$597.48 | -$71,837,410.32 | -30.06% | 279.77K |
Jun 9
| |||||||
Regeneron Pharmaceuticals, Inc.
| -22.82M |
$509.85 | -$11,635,516,792.35 | -98.28% | 400K |
May 29
| |||||||
Regeneron Pharmaceuticals, Inc.
| -128.91K |
$489.65 | -$63,123,152.62 | -0.63% | 20.42M |
Mar 9
| |||||||
Regeneron Pharmaceuticals, Inc.
| -172.90K |
$281.15 | -$48,611,803.99 | -0.83% | 20.55M |
Sep 10
| |||||||
Fulcrum Therapeutics, Inc.
| 558.03K |
$16.00 | $1,500,000.00 |
∞
| 558.03K |
Jul 22
| |||||||
Fulcrum Therapeutics, Inc.
|
0
|
—
|
—
|
—
|
0
| ||||||||
Regeneron Pharmaceuticals Inc
| -131.12K |
$412.17 | -$54,041,315.54 | -0.63% | 20.72M |
Mar 8
| |||||||
Myokardia Inc
| -4.17M |
$37.66 | -$157,000,736.34 | -100.00% |
0
|
Feb 13
| |||||||
Alnylam Pharmaceuticals, Inc.
|
0
|
—
|
—
|
—
|
0
| ||||||||
Regeneron Pharmaceuticals Inc
| -104.55K |
$406.68 | -$42,519,249.18 | -0.44% | 23.65M |
Sep 6
| |||||||
Regeneron Pharmaceuticals Inc
| -121.60K |
$309.31 | -$37,611,882.43 | -0.51% | 23.76M |
Jun 8
| |||||||
Myokardia Inc
| 150K |
$49.00 | $7,350,000.00 | +3.73% | 4.17M |
May 25
| |||||||
Regeneron Pharmaceuticals Inc
| 72.38K |
$481.36 | $34,840,132.96 | +0.30% | 23.88M |
Aug 25
| |||||||
Regeneron Pharmaceuticals Inc
| 166.41K |
$480.93 | $80,033,622.17 | +0.70% | 23.81M |
Aug 23 - Aug 24
| |||||||
Myokardia Inc
| 350K |
$35.50 | $12,425,000.00 | +9.54% | 4.02M |
Aug 14
| |||||||
Regeneron Pharmaceuticals Inc
| 136.05K |
$478.17 | $65,055,558.00 | +0.58% | 23.64M |
Jun 2
| |||||||
Alnylam Pharmaceuticals, Inc.
| 297.5K |
$71.87 | $21,381,396.87 | +2.90% | 10.55M |
May 31
| |||||||
Regeneron Pharmaceuticals Inc
| 87.3K |
$369.71 | $32,274,871.70 | +0.37% | 23.51M |
Jan 11
| |||||||
Myokardia Inc
| 450K |
$15.00 | $6,750,000.00 | +13.98% | 3.67M |
Oct 3
| |||||||
Regeneron Pharmaceuticals Inc
| 64.73K |
$363.86 | $23,552,858.70 | +0.28% | 23.42M |
Jun 14
| |||||||
Regeneron Pharmaceuticals Inc
| 161.16K |
$392.46 | $63,247,909.95 | +0.69% | 23.35M |
Feb 16 - Feb 17
| |||||||
Alnylam Pharmaceuticals, Inc.
| 205.03K |
$69.75 | $14,300,842.50 | +2.04% | 10.26M |
Feb 1
| |||||||
Regeneron Pharmaceuticals Inc
| 83.94K |
$465.04 | $39,034,660.20 | +0.36% | 23.19M |
Jan 12
| |||||||
Voyager Therapeutics, Inc.
| 2.48M |
$14.00 | $1,750,000.00 |
∞
| 2.48M |
Nov 10 - Nov 16
| |||||||
Voyager Therapeutics, Inc.
|
0
|
—
|
—
|
—
|
0
| ||||||||
Myokardia Inc
| 3.22M |
$10.00 | $9,000,000.00 |
∞
| 3.22M |
Nov 3
| |||||||
Myokardia Inc
|
0
|
—
|
—
|
—
|
0
| ||||||||
Regeneron Pharmaceuticals Inc
| 11.04K |
$472.33 | $5,214,518.70 | +0.05% | 23.11M |
Oct 6
| |||||||
Regeneron Pharmaceuticals Inc
| 80.54K |
$459.71 | $37,024,196.88 | +0.35% | 23.1M |
Oct 6
| |||||||
Regeneron Pharmaceuticals Inc
| 147.21K |
$534.67 | $78,708,569.98 | +0.64% | 23.02M |
Sep 23
| |||||||
Regeneron Pharmaceuticals Inc
| 10.64K |
$537.48 | $5,718,271.92 | +0.05% | 22.87M |
Jul 27
|
Scheduled
| ||||||
Alnylam Pharmaceuticals, Inc.
| 97.12K |
$95.00 | $9,226,210.00 | +0.98% | 10.05M |
Jan 29
| |||||||
Alnylam Pharmaceuticals, Inc.
| 196.25K |
$93.17 | $18,284,705.67 | +2.15% | 9.31M |
Jan 22
| |||||||
It looks like there's no data for these filter options. Maybe you'll be interested in these options instead. | |||||||||||||
Want to view more results?
Unlock the hidden results with your Benzinga Account now. No purchase required.